Stella K. Vnook’s Post

We're excited to invite you to a special presentation at the upcoming Global Cell & Gene Therapy Summit in Boston, MA on Tuesday, July 9th. Don't miss this opportunity to gain invaluable insights from Likarda CEO, Dr. Stella K. Vnook. 📅 Date: Tuesday, July 9 🕓 Time: 4:00 PM 📍 Location: The Global Cell and Gene Therapy Summit: https://cgtsummit.com Dr. Stella K. Vnook will delve into the latest advancements and innovative strategies in cell therapy cryopreservation and logistics, exploring how these can revolutionize therapeutic applications. Whether you’re a researcher, healthcare professional, or industry leader, you’ll find the presentation packed with cutting-edge information and practical insights. Make sure to mark your calendar and be part of this enlightening discussion. To meet with us personally at the conference, please email us at meetus@likarda.com. #CellTherapy #GeneTherapy #Biotech #Cryopreservation #HealthcareInnovation

In this interview, produced in partnership with Bullpen at #BIO2024, Stella K. Vnook (Likarda) and Ranjeet Banerjee (Cold Chain Technologies) discuss the intricacies of the companies' partnership, the benefits of being a Bullpen member, and what the future holds for both the companies, as well as the field. 📽 Watch the full interview, below 👇 https://lnkd.in/g4cyxd55 #BIO24 #Cyropreservation #CellTherapy #AdvancedTherapies #Investment

In this new industry roundtable on Pharma's Almanac, SMEs from across the industry discuss how technology providers can help transition to more digitally connected operations. Our panel includes experts from TriRx Pharmaceutical Services, LLC, GBI Biomanufacturing, Quotient Sciences, Nu-Tek BioSciences, Mikart, LLC, Oxford Biomedica, PCI Pharma Services, Samsung Biologics, SCIEX, Cytiva, Cambrex, Astrea Bioseparations, BioIVT, LabVantage Solutions, Inc, Lonza, SK pharmteco, Thermo Fisher Scientific, OM1, Inc., Bruker BioSpin, MilliporeSigma, Certara, eClinical Solutions, ProPharma, ScaleReady, Green Elephant Biotech, Likarda, Terumo Blood and Cell Technologies, NextCell Pharma AB, VIVEbiotech, OrganoBiotech, Inc., and IDBS.

Big News — Groundbreaking Partnership between Likarda and Cold Chain Technologies At Likarda, we don’t just innovate; we revolutionize. We're thrilled to announce our exclusive partnership with Cold Chain Technologies (CCT), set to redefine cell therapy logistics and make these life-saving treatments more accessible globally. By integrating Likarda’s Core-Shell Spherification® (CSS®) technology with CCT’s advanced cold chain solutions, we can eliminate the need for extremely low-temperature transport, which can be troublesome. Our CSS® technology prevents ice crystal formation and shields biological materials from mechanical damage, ensuring cell therapies remain stable and effective throughout their journey. Stella K. Vnook, Likarda’s CEO, states, “This collaboration sets new standards for the storage and transportation of cell therapies, improving the safety and reliability of these sensitive materials.” CCT's CEO, Ranjeet Banerjee, adds, “We are excited to partner with Likarda to develop and commercialize this transformative technology, paving the way for a more efficient, cost-effective, and scalable model to bring these lifesaving therapies to patients.” Together, we are ensuring that the future of medicine is innovative and accessible. Make sure to follow along as we continue to push the boundaries in biotech and logistics. Read the full press release here: https://bit.ly/3Rg8N1d #CellTherapy #HealthcareInnovation #Biotech #BIO2024

Meet Stella K. Vnook in the Bullpen during BIO International Convention in San Diego June 2 - 5. Join us at the Garage Collective for a different kind of "zoom" meeting: https://lnkd.in/gw47jDiN Request a ticket here: https://lnkd.in/dVNxiqNi #Bullpen #BIO2024 #SanDiego #Venture #Funding #CarShow #KOL #Panels #Interviews #Partnering #FoodTrucks #Help #Repeat Thank you to our Supporters: Silicon Valley Bank New York City Economic Development Corporation EisnerAmper Euroleader Orrick, Herrington & Sutcliffe LLP Collaborative Drug Discovery - CDD Vault CSC Leasing Sequoia Biotech Consulting CURE ChromaTan, Inc TheraXyte BioScience SohoMD, PLLC Beda J.P. Morgan Veranex Mercury Tulane University Mazzetti Snell & Wilmer Buzzed for Biotech OrganaBio LabOps Unite Community MTEC | Medical Technology Enterprise Consortium Likarda Emily Whitehead Foundation IB Communications Evia Bio SciLeads Christiaan & Company D3 Digital Media Marketing Women And AI Orange County Bio

🎬 𝐓𝐡𝐞 𝐀𝐝𝐮𝐥𝐭’𝐬 𝐓𝐚𝐛𝐥𝐞: 𝐄𝐩𝐢𝐬𝐨𝐝𝐞 𝟏𝟎 𝐰𝐢𝐭𝐡 𝐒𝐭𝐞𝐥𝐥𝐚 𝐕𝐧𝐨𝐨𝐤 📺 𝐖𝐚𝐭𝐜𝐡 𝐭𝐡𝐞 𝐄𝐩𝐢𝐬𝐨𝐝𝐞: "Helping Brilliant Minds Make Life-Changing Medicines" Let me introduce Stella K. Vnook. She is the CEO of Likarda and Founder and President of Oral Biolife Inc. Stella also founded the Agile Consulting Group (ACG) to help brilliant minds take early-stage R&D projects and reach commercialization. She is a prolific speaker on several life sciences topics both strategic and technical. 🔍 𝐓𝐡𝐞 𝐏𝐫𝐨𝐛𝐥𝐞𝐦s: First, scientists often don’t have business backgrounds or funding connections. Some struggle to communicate their vision, raise money, build teams, and commercialze. Second, drug delivery technology is usually lower on the priority list during development and clinical trials. Once the final formulation is approved, it’s extremely difficult to introduce medicine delivery technology without regulatory hurdles and pain. 💡 𝐒𝐭𝐞𝐥𝐥𝐚’𝐬 𝐒𝐮𝐩𝐞𝐫𝐩𝐨𝐰𝐞𝐫: Stella is a superconnector and puts patients first. She is a well connected cell therapy scientist and MBA who knows the funding and operational aspects of starting therapeutic companies. This allows her to see potential in R&D IP and people, then connect them with the right resources to go from idea to a funded company. Likarda recognized Stella’s superpower to identify scientific solutions for unmet clinical needs and transform them into viable business strategies. 📈 𝐑𝐞𝐬𝐮𝐥𝐭𝐬: Likarda is advancing its Core-Shell Spherification® (CSS) platform and partnering with drug companies to improve cell therapy delivery. Another of Stella's companies, Oral Biolife, is revolutionizing bone regeneration for oral diseases. Stella also continues to help life sciences companies/teams bring life-changing medicines to market. 🤝 𝐆𝐞𝐭 𝐢𝐧 𝐓𝐨𝐮𝐜𝐡: Stella is a leading voice in life sciences and cell therapy. If you are an entrepreneurial scientist with a great idea or IP, a PE stakeholder looking to understand M&A opportunities, or a cell therapy company; reach out to Stella to see how she can help you. 🍽️ 𝐖𝐡𝐚𝐭 𝐢𝐬 𝐭𝐡𝐞 𝐀𝐝𝐮𝐥𝐭’𝐬 𝐓𝐚𝐛𝐥𝐞? It's a platform where we spotlight the strategic problem-solving prowess of executives. We eschew jargon and get straight to the point, sharing stories and insights that resonate with fellow executives. 🎤 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐉𝐨𝐢𝐧 𝐭𝐡𝐞 𝐒𝐡𝐨𝐰? Don't hesitate to reach out to me to explore if it's a good fit. 📲 Let's continue the conversation and unlock strategic solutions together! Please share with your network, follow me Ronald Eggert and Propellant Consulting on LinkedIn and YouTube. 𝐕𝐢𝐞𝐰 𝐨𝐧 𝐨𝐮𝐫 𝐖𝐞𝐛𝐬𝐢𝐭𝐞: https://lnkd.in/eAsuZAZD 𝐅𝐨𝐥𝐥𝐨𝐰 𝐨𝐧 𝐋𝐢𝐧𝐤𝐞𝐝𝐈𝐧: https://lnkd.in/dV7kB8Kz 𝐕𝐢𝐞𝐰 𝐅𝐮𝐥𝐥 𝐄𝐩𝐢𝐬𝐨𝐝𝐞 𝐨𝐧 𝐘𝐨𝐮𝐓𝐮𝐛𝐞: https://lnkd.in/eMtAvdix #Pharma #Biotechnology #LifeSciences #CellTherapy #DrugDelivery #BoneRegeneration